85 related articles for article (PubMed ID: 21688971)
1. Assessing toxicity of polyamidoamine dendrimers by neuronal signaling functions.
Nyitrai G; Kékesi O; Pál I; Keglevich P; Csíki Z; Fügedi P; Simon A; Fitos I; Németh K; Visy J; Tárkányi G; Kardos J
Nanotoxicology; 2012 Sep; 6(6):576-86. PubMed ID: 21688971
[TBL] [Abstract][Full Text] [Related]
2. Polyamidoamine dendrimer impairs mitochondrial oxidation in brain tissue.
Nyitrai G; Héja L; Jablonkai I; Pál I; Visy J; Kardos J
J Nanobiotechnology; 2013 Apr; 11():9. PubMed ID: 23556550
[TBL] [Abstract][Full Text] [Related]
3. Sodium selective ion channel formation in living cell membranes by polyamidoamine dendrimer.
Nyitrai G; Keszthelyi T; Bóta A; Simon A; Tőke O; Horváth G; Pál I; Kardos J; Héja L
Biochim Biophys Acta; 2013 Aug; 1828(8):1873-80. PubMed ID: 23597947
[TBL] [Abstract][Full Text] [Related]
4. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
Albertazzi L; Gherardini L; Brondi M; Sulis Sato S; Bifone A; Pizzorusso T; Ratto GM; Bardi G
Mol Pharm; 2013 Jan; 10(1):249-60. PubMed ID: 23163881
[TBL] [Abstract][Full Text] [Related]
5. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
6. Polyamidoamine dendrimers surface-engineered with biomimetic phosphorylcholine as potential drug delivery carriers.
Jia L; Xu JP; Wang H; Ji J
Colloids Surf B Biointerfaces; 2011 May; 84(1):49-54. PubMed ID: 21237622
[TBL] [Abstract][Full Text] [Related]
7. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
8. In vivo toxicity of poly(propyleneimine) dendrimers.
Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451
[TBL] [Abstract][Full Text] [Related]
9. Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells.
Zeng Y; Kurokawa Y; Win-Shwe TT; Zeng Q; Hirano S; Zhang Z; Sone H
J Toxicol Sci; 2016; 41(3):351-70. PubMed ID: 27193728
[TBL] [Abstract][Full Text] [Related]
10. Studies on polyamidoamine dendrimers as efficient gene delivery vector.
Hui Zhong ; He ZG; Zheng Li ; Li GY; Shen SR; Li XL
J Biomater Appl; 2008 May; 22(6):527-44. PubMed ID: 17623709
[TBL] [Abstract][Full Text] [Related]
11. Effects of PAMAM dendrimers in the mouse brain after a single intranasal instillation.
Win-Shwe TT; Sone H; Kurokawa Y; Zeng Y; Zeng Q; Nitta H; Hirano S
Toxicol Lett; 2014 Aug; 228(3):207-15. PubMed ID: 24813635
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
Zhang XQ; Intra J; Salem AK
Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
[TBL] [Abstract][Full Text] [Related]
13. Low-generation asymmetric dendrimers exhibit minimal toxicity and effectively complex DNA.
Shah N; Steptoe RJ; Parekh HS
J Pept Sci; 2011 Jun; 17(6):470-8. PubMed ID: 21351322
[TBL] [Abstract][Full Text] [Related]
14. PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats.
Labieniec M; Ulicna O; Vancova O; Glowacki R; Sebekova K; Bald E; Gabryelak T; Watala C
Int J Pharm; 2008 Nov; 364(1):142-9. PubMed ID: 18761397
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl group-terminated polyamidoamine dendrimers bearing glucosides inhibit intestinal hexose transporter-mediated D-glucose uptake.
Sakuma S; Teraoka Y; Sagawa T; Masaoka Y; Kataoka M; Yamashita S; Shirasaka Y; Tamai I; Ikumi Y; Kida T; Akashi M
Eur J Pharm Biopharm; 2010 Aug; 75(3):366-74. PubMed ID: 20399853
[TBL] [Abstract][Full Text] [Related]
16. Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia.
Bertero A; Boni A; Gemmi M; Gagliardi M; Bifone A; Bardi G
Nanotoxicology; 2014 Mar; 8(2):158-68. PubMed ID: 23298388
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of PAMAM Dendrimers Internalization in Hippocampal Neurons.
Vidal F; Vásquez P; Díaz C; Nova D; Alderete J; Guzmán L
Mol Pharm; 2016 Oct; 13(10):3395-3403. PubMed ID: 27556289
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residues.
Kumar A; Yellepeddi VK; Vangara KK; Strychar KB; Palakurthi S
J Drug Target; 2011 Nov; 19(9):770-80. PubMed ID: 21457075
[TBL] [Abstract][Full Text] [Related]
19. The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers.
Wang S; Li Y; Fan J; Wang Z; Zeng X; Sun Y; Song P; Ju D
Biomaterials; 2014 Aug; 35(26):7588-97. PubMed ID: 24906346
[TBL] [Abstract][Full Text] [Related]
20. PAMAM dendrimers conjugated with an uncharged gadolinium(III) chelate with a fast water exchange: the influence of chelate charge on rotational dynamics.
Polásek M; Hermann P; Peters JA; Geraldes CF; Lukes I
Bioconjug Chem; 2009 Nov; 20(11):2142-53. PubMed ID: 19883075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
